Drug Security Forum

Diabetes mellitus is one of the top three diseases worldwide that most often lead to disability and death. In Russia, the number of patients with diabetes has increased 2.5-fold over the past 20 years. The rapid development of new age medicine has opened up new opportunities in the diagnosis and treatment of this complex disease. The development of molecular genetic research has made it possible to improve diagnosis and use a personalized approach to treatment. The use of modern antidiabetic drugs helps prevent the development of acute complications and delay the development of cardiovascular complications in type II diabetes. The development of drugs for immunotherapy of type I diabetes is underway. The emergence of new medical devices and digital technologies, including continuous glucose monitors, smart insulin pens, feedback-enabled insulin pumps, personal health assistants, mobile apps, telemedicine services, and AI systems have significant potential to improve the quality of care and treatment outcomes. Technologies such as bionic or artificial pancreas are expected in the future, with high hopes for the application of stem cell technologies. What innovative technologies for the treatment of diabetes are now available globally and are accessible in Russia? What promising developments in medicines and medical devices are taking place in our country? What technologies are most needed medically? How can we accelerate the introduction of digital technologies into the treatment of patients with diabetes? Which best practices from foreign countries can be used in our country?

Moderator
Anastasia Stolkova, First Deputy Chief Executive Officer for Development, Director of the Healthcare Directorate, Roscongress Foundation

Anastasia Stolkova

First Deputy Chief Executive Officer for Development, Director of the Healthcare Directorate, Roscongress Foundation

Panellists
Elena Aksenova, Director, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department
Gagik Galstyan, President, Russian Diabetes Association (online)
Vasily Generalov, President, Regional Public Organization for Assistance to Patients with Epilepsy "Project" Don't Be Afraid"
Roman Dray, Director of the Research Centre, GEROPHARM
Svetlana Kanevskaya, Medical Director, Medscan Group
Sergei Lukyanov, Rector, Pirogov Russian National Research Medical University
Natalia Mokrysheva, Director, National Medical Research Center for Endocrinology Ministry of Health of the Russian Federation (online)
Elena Petryaykina, Director, Russian Children's Clinical Hospital of the Russian National Research Medical University named after N.I. Pirogov

Elena Aksenova

Director, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

Elena Aksenova has been working at the Research Institute since December 2018.
Educated at Moscow State Pedagogical University, National Research University Higher School of Economics, Russian Presidential Academy of National Economy and Public Administration.
She worked as Vice-Rector for Development and Innovation at the I.M. Sechenov First Moscow State Medical University of the Russian Ministry of Health. She was Deputy Head of the Department of Innovative Development of Medical Science of RAMS, Head of the Expert Analytical Department of the Federal Agency for Scientific Organizations, Deputy Chief Scientific Secretary of the Presidium of the Russian Academy of Sciences.
Before assuming the position of Director of the Research Institute for Innovative Development of Medical Science of the DSMH, she was the Head of the Center for Strategic Planning of Science Development, Expertise and Scientific Advice of the RAS.

Vasily Generalov

President, Regional Public Organization for Assistance to Patients with Epilepsy "Project" Don't Be Afraid"

Svetlana Kanevskaya

Medical Director, Medscan Group

Sergei Lukyanov

Rector, Pirogov Russian National Research Medical University

Sergey Lukyanov graduated from Lomonosov Moscow State University in 1985, majoring in Physiology. In 1986, started working at the Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, rising in the ranks from Research Assistant to Head of Laboratory.
In 1994, he successfully defended his PhD dissertation ‘Cloning of a novel Xenopus homeobox gene XANF-1 by subtractive hybridization,’ which he completed at the Laboratory of Structure and Function of Human Genes under the supervision of Prof. Eugene D. Sverdlov. In 1999, he successfully defended his doctoral (DrSc) disseration ‘Selective suppression of polymerase chain reaction’ at the Institute of Bioorganic Chemistry, advised by Prof. Eugene D. Sverdlov.
In 2003, he became a Corresponding Member of the Russian Academy of Science and became a full Academician of the Russian Academy of Sciences in 2011.
In 2010–2014, he received a mega grant from the Russian Government to create a fluorescent bio-imaging laboratory at Nizhny Novgorod State Medical Academy (now Privolzhsky Research Medical University). This laboratory became the foundation of the NNSMA Biomedical Technology Research Institute. In 2012–2013, served as Acting Assistant to the Minister of Health of the Russian Federation. In 2013–2015, was the Vice Rector of the Pirogov Russian National Research Medical University (RNRMU). He became Acting Rector on 29 April 2015 and was elected the Rector of RNRMU in 2016.
Over the course of his work, Lukyanov published more than 180 research papers in Russian and foreign journals (with an h-index of 58 and a ‘sum of times cited’ over 18,000 according to Web of Science) and patented 51 inventions.
In 2006, he was awared the Russian Academy of Sciences Ovchinnikov Prize for outstanding work in physicochemical biology and biotechnology for his paper ‘Fluorescent proteins: finding, investigation and use in biotechnology.’ In 2012, he was awarded the RUSNANOPRIZE Nanotechnology International Prize. In 2015, he was conferred the Russian Federation National Award in science and technology for the development and implementation of a technological complex for the analysis of compound genome structure and functions.

Natalia Mokrysheva

Director, National Medical Research Center for Endocrinology Ministry of Health of the Russian Federation

Elena Petryaykina

Director, Russian Children's Clinical Hospital of the Russian National Research Medical University named after N.I. Pirogov

Front row participants
Bulat Valitov, Doctor of the Russian Mini-Football Team for People with Diabetes; Head, Author's Online Diabetes School
Tamara Kozyreva, Head, Help First Project

Bulat Valitov

Doctor of the Russian Mini-Football Team for People with Diabetes; Head, Author's Online Diabetes School